Market News

Clearline Capital LP Has Raised Holding in Rayonier Advanced Matls (RYAM) as Share Value Rose; Carroll Financial Associates Boosted Its Pfizer Com (PFE) Position by $519,190; Stock Price Declined

Carroll Financial Associates Inc increased its stake in Pfizer Inc Com (PFE) by 6.73% based on its latest 2017Q3 regulatory filing with the SEC. Carroll Financial Associates Inc bought 14,834 shares as the company’s stock declined 3.45% while stock markets rallied. The institutional investor held 235,139 shares of the health care company at the end of 2017Q3, valued at $8.47M, up from 220,305 at the end of the previous reported quarter. Carroll Financial Associates Inc who had been investing in Pfizer Inc Com for a number of months, seems to be bullish on the $221.62B market cap company. The stock increased 1.58% or $0.58 during the last trading session, reaching $37.18. About 24.03 million shares traded or 53.11% up from the average. Pfizer Inc. (NYSE:PFE) has declined 2.76% since January 18, 2017 and is downtrending. It has underperformed by 19.46% the S&P500.

Marc Majzner increased its stake in Rayonier Advanced Matls Inc (RYAM) by 196.42% based on its latest 2017Q3 regulatory filing with the SEC. Clearline Capital Lp bought 165,882 shares as the company’s stock rose 2.81% with the market. The hedge fund run by Marc Majzner held 250,333 shares of the major chemicals company at the end of 2017Q3, valued at $3.43 million, up from 84,451 at the end of the previous reported quarter. Clearline Capital Lp who had been investing in Rayonier Advanced Matls Inc for a number of months, seems to be bullish on the $832.21 million market cap company. The stock decreased 1.33% or $0.26 during the last trading session, reaching $19.23. About 720,783 shares traded or 3.16% up from the average. Rayonier Advanced Materials Inc. (NYSE:RYAM) has risen 2.89% since January 18, 2017 and is uptrending. It has underperformed by 13.81% the S&P500.

Since August 4, 2017, it had 0 insider purchases, and 10 selling transactions for $16.36 million activity. DAMELIO FRANK A had sold 94,409 shares worth $3.21 million on Thursday, August 31. $502,560 worth of Pfizer Inc. (NYSE:PFE) shares were sold by MACKENZIE ALEXANDER R. Another trade for 8,064 shares valued at $263,693 was made by OLSON LAURIE J on Monday, August 21. $1.34M worth of Pfizer Inc. (NYSE:PFE) was sold by SUSMAN SALLY. 8,000 shares were sold by JOHNSON RADY A, worth $296,560.

Among 21 analysts covering Pfizer (NYSE:PFE), 9 have Buy rating, 1 Sell and 11 Hold. Therefore 43% are positive. Pfizer had 68 analyst reports since July 29, 2015 according to SRatingsIntel. The stock of Pfizer Inc. (NYSE:PFE) earned “Overweight” rating by Barclays Capital on Tuesday, November 29. The firm earned “Neutral” rating on Wednesday, November 25 by Suntrust Robinson. The rating was upgraded by SunTrust to “Neutral” on Wednesday, November 25. As per Monday, April 18, the company rating was maintained by Goldman Sachs. The rating was maintained by Argus Research on Wednesday, July 29 with “Buy”. BMO Capital Markets maintained it with “Buy” rating and $37.0 target in Tuesday, September 5 report. The firm has “Overweight” rating given on Friday, October 2 by Morgan Stanley. The rating was maintained by Jefferies on Tuesday, June 14 with “Buy”. The firm has “Outperform” rating by BMO Capital Markets given on Thursday, October 19. The firm earned “Buy” rating on Monday, June 20 by Jefferies.

Investors sentiment increased to 0.96 in Q3 2017. Its up 0.02, from 0.94 in 2017Q2. It increased, as 53 investors sold PFE shares while 700 reduced holdings. 106 funds opened positions while 620 raised stakes. 4.06 billion shares or 0.86% more from 4.02 billion shares in 2017Q2 were reported. Wellington Shields Limited Liability Corp accumulated 0.68% or 57,284 shares. Cheviot Value Llc invested 4.47% of its portfolio in Pfizer Inc. (NYSE:PFE). Albion Grp Inc Ut has invested 0.14% of its portfolio in Pfizer Inc. (NYSE:PFE). Heritage Invsts Mngmt Corp has invested 0.97% in Pfizer Inc. (NYSE:PFE). Logan Capital Mngmt stated it has 1.34% in Pfizer Inc. (NYSE:PFE). Millennium Mgmt Limited Liability Corporation invested 0.13% in Pfizer Inc. (NYSE:PFE). Marco Investment Limited Liability Corporation reported 158,977 shares stake. John G Ullman & Associates reported 460,789 shares. Palisade Management Llc Nj holds 0.11% or 90,303 shares. Conestoga Capital Advisors Ltd Com accumulated 17,635 shares or 0.03% of the stock. Laffer Invs reported 21,023 shares. Rhumbline Advisers reported 0.74% of its portfolio in Pfizer Inc. (NYSE:PFE). Diversified Tru accumulated 24,647 shares or 0.07% of the stock. Lenox Wealth Advsrs Inc stated it has 818 shares. Legacy Private Trust stated it has 0.26% in Pfizer Inc. (NYSE:PFE).

Carroll Financial Associates Inc, which manages about $1.57 billion and $877.90 million US Long portfolio, decreased its stake in Spdr S&P 600 Small Cap Value Etf by 11,224 shares to 251 shares, valued at $32,000 in 2017Q3, according to the filing. It also reduced its holding in Exxon Mobil Corp Com (NYSE:XOM) by 3,867 shares in the quarter, leaving it with 219,767 shares, and cut its stake in Spdr S&P 500 Etf (SPY).

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.


Leave a Reply

Your email address will not be published. Required fields are marked *